Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYMedicina (Kaunas, Lithuania)

Prognostic Value of a Seven-Factor Risk Stratification System in T3N0 Colon Cancer: A Single-Center Retrospective Study

  • Abdussamet Çelebi1
  • Eren Meral2
  • Fırat Akagündüz1
  • Ahmet Demirel1
  • Mustafa Alperen Tunç1
  • Burak Paçacı1
  • Erkam Kocaaslan1
  • Ali Kaan Güren1
  • Selver Işık1
  • Ezgi Çoban1
  • Nazım Can Demircan1
  • Osman Köstek1
2 more authors
  • İbrahim Vedat Bayoğlu1
  • Murat Sarı1
  1. 1Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul 34899, Türkiye; (F.A.); (A.D.); (M.A.T.); (B.P.); (E.K.); (A.K.G.); (S.I.); (E.Ç.); (N.C.D.); (O.K.); (İ.V.B.)
  2. 2Department of Internal Medicine, Faculty of Medicine, Marmara University, Istanbul 34899, Türkiye;
Read full textPDFCite

Related

  1. Transcription factor-driven metabolic stratification reveals glycolytic and lipogenic subtypes with distinct prognostic and functional features in pancreatic cancer
    Jie Ke, Shuai Liu, Junming Xu +1
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  2. Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma
    Tamara Künzle, Dora Herzi, Clara Boer Wigman +20
    Neuro-OncologyPeer-reviewedPublisher termsFull textNeurologyPMC
  3. Lymph Node Regression Improves Prognostic Stratification in Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Cohort Study.
    Jian Zheng, Wenbin Shen, Jianzhong Cao +13
    MedCommPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  4. Validation and prognostic utility of the mSMART 4.0 risk stratification system in Chinese patients with multiple myeloma
    Jian Yin, Rui Liu, Yanping Zhang +3
    BMC CancerPeer-reviewedCC BYFull textOncologyDOAJ
  5. Treatment-Free Interval as a Prognostic Factor for Survival Outcomes in Patients with Advanced or Recurrent Endometrial Cancer Treated with Pembrolizumab Plus Lenvatinib: A Multi-Institutional Real-World Cohort Study
    Chih-Wen Su, Shao-Jing Wang, Yu-Hsiang Shih +9
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{celebi2026prognostic,
  title = {{Prognostic Value of a Seven-Factor Risk Stratification System in T3N0 Colon Cancer: A Single-Center Retrospective Study}},
  author = {Abdussamet Çelebi and Eren Meral and Fırat Akagündüz and Ahmet Demirel and Mustafa Alperen Tunç and Burak Paçacı and Erkam Kocaaslan and Ali Kaan Güren and Selver Işık and Ezgi Çoban and Nazım Can Demircan and Osman Köstek and İbrahim Vedat Bayoğlu and Murat Sarı},
  journal = {Medicina (Kaunas, Lithuania)},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13706934},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Prognostic Value of a Seven-Factor Risk Stratification System in T3N0 Colon Cancer: A Single-Center Retrospective Study
AU  - Abdussamet Çelebi
AU  - Eren Meral
AU  - Fırat Akagündüz
AU  - Ahmet Demirel
AU  - Mustafa Alperen Tunç
AU  - Burak Paçacı
AU  - Erkam Kocaaslan
AU  - Ali Kaan Güren
AU  - Selver Işık
AU  - Ezgi Çoban
AU  - Nazım Can Demircan
AU  - Osman Köstek
AU  - İbrahim Vedat Bayoğlu
AU  - Murat Sarı
PY  - 2026
DA  - 2026/09/24
JO  - Medicina (Kaunas, Lithuania)
UR  - https://europepmc.org/article/PMC/PMC13706934
SN  - 1010-660X
SN  - 1648-9144
ER  -